Iowa Administrative Code › Agency 653 - Medicine Board › Chapter 19 - Prescribing Psychologists › Rule 653-19.6 - Collaborative Practice-joint Rule

Current through Register Vol. 47, No. 3, July 24, 2024
(1) A prescribing psychologist shall have one
			 or more collaborating physicians at all times, as evidenced by a current
			 collaborative practice agreement. Prior to executing a collaborative practice
			 agreement, a prescribing psychologist and a collaborating physician shall
			 review and discuss each other's relevant education, training, experience, and
			 competencies to determine whether a collaborative practice is appropriate and
			 to facilitate drafting a suitable collaborative practice agreement. A
			 collaborative relationship between a prescribing psychologist and a
			 collaborating physician shall ensure patient safety and optimal clinical
			 outcomes. Collaboration may be done in person or via electronic communication
			 in accordance with these rules. A physician shall not serve as a collaborating
			 physician for more than two prescribing psychologists at one time. A
			 prescribing psychologist shall not prescribe without a current written
			 collaborative practice agreement with a collaborating physician in place. All
			 collaborative relationships shall be reviewed and evaluated on an annual basis
			 to ensure that the prescribing psychologist is competent to safely prescribe
			 psychotropic medications to patients and that the collaborating physician is
			 providing appropriate feedback to the prescribing psychologist. A collaborative
			 practice agreement shall establish the parameters of the collaborative practice
			 that are mutually agreed upon by the prescribing psychologist and the
			 collaborating physician and shall be reviewed on an annual basis.
(2) A collaborative practice agreement shall
			 include the following:
a.
Prescribing
			 psychologist information.
The name, license number, DEA registration
			 number, CSA registration number, address, telephone number, email address, and
			 practice locations of the prescribing psychologist.
b.
Collaborating physician
			 information.
The name, license number, DEA registration number, CSA
			 registration number, address, telephone number, email address, and practice
			 locations of the collaborating physician.
c.
lime period.
The time
			 period covered by the agreement.
d.
Locations and settings.
The locations and settings where
			 collaborative practice will occur.
e.
Collaboration.
A
			 provision indicating that the collaborating physician and prescribing
			 psychologist shall ensure that the collaborating physician is available for
			 timely collaboration with a prescribing psychologist, either in person or via
			 electronic communication, in accordance with these rules.
f.
Scope of practice.
The
			 scope of practice agreed upon by the collaborating physician and the
			 prescribing psychologist, as it relates to the prescribing psychologist's
			 prescribing of psychotropic medications, including provisions to ensure that
			 the prescribing psychologist's practice complies with all provisions of these
			 rules.
g.
Clinical
			 protocols, practice guidelines, and care plans.
Clinical protocols,
			 practice guidelines, and care plans relevant to the scope of practice
			 authorized.
h.
Methods of
			 communication.
A description of how a prescribing psychologist and a
			 collaborating physician may contact each other for consultation.
i.
Limitations on psychotropic
			 medications.
A description of any limitations on the range of
			 psychotropic medications the prescribing psychologist may prescribe. The
			 collaborative practice agreement shall also include a provision indicating that
			 the collaborating physician and prescribing psychologist shall ensure that the
			 prescribing psychologist only prescribes psychotropic medications that are
			 consistent with the prescribing psychologist's education, training, experience,
			 and competence.
j.
Limitations on patient populations.
A description of any
			 limitations on the types of populations that the prescribing psychologist may
			 treat with psychotropic medications. The collaborative practice agreement shall
			 also include a provision indicating that the collaborating physician and
			 prescribing psychologist shall ensure that the prescribing psychologist only
			 provides psychopharmacology services to patient populations that are within the
			 prescribing psychologist's education, training, experience, and
			 competence.
k.
Release of
			 information.
A provision requiring the prescribing psychologist to
			 obtain a release of information from all patients who are considered for
			 psychopharmacological intervention, authorizing the prescribing psychologist to
			 share the patient's health information with the collaborating physician.
l.
Chart review.
A
			 provision indicating that the collaborating physician and prescribing
			 psychologist shall ensure that the collaborative physician personally reviews
			 and documents review of at least 10 percent of the prescribing psychologist's
			 patient charts on a quarterly basis in each of the following categories:
(1) Juvenile patients,
(2) Pregnant or lactating patients,
(3) Elderly patients,
(4) Patients with serious medical conditions,
			 and
(5) All other
			 patients.
m.
Annual review.
A provision requiring an annual review and
			 evaluation of the collaborative relationship and the collaborative practice
			 agreement.
n.
Consultation
			 between the prescribing psychologist and the collaborating physician.
A provision requiring that the prescribing psychologist consult with the
			 collaborating physician on a regular basis regarding the patient's psychotropic
			 treatment plan and any potential complications. A prescribing psychologist
			 shall not prescribe a new psychotropic medication, discontinue a psychotropic
			 medication, or change the dosage of a psychotropic medication if the
			 collaborating physician objects on the basis of a contraindication.
o.
Consultation between the
			 collaborating physician and the primary care physician.
A provision
			 requiring that the collaborating physician consult with the patient's primary
			 care physician on a regular basis regarding the patient's psychotropic
			 treatment plan and any potential complications.
p.
Termination.
A provision
			 describing how the agreement can be terminated and the process for notifying
			 affected patients if there will be an interruption in services.
q.
Signatures.
Signatures of
			 the prescribing psychologist and all collaborating physicians.